Literature DB >> 21948647

Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.

Matthias Zenkel1, Anita Krysta, Francesca Pasutto, Anselm Juenemann, Friedrich E Kruse, Ursula Schlötzer-Schrehardt.   

Abstract

PURPOSE: Pseudoexfoliation (PEX) syndrome/glaucoma is a complex, late-onset disorder of the elastic fiber system. Strong genetic risk is conferred by the lysyl oxidase-like 1 (LOXL1) gene, but additional comodulating factors are necessary for the manifestation of the disease. The aim of this study was to analyze the effect of various PEX-associated pathogenic factors on the genotype-correlated expression of LOXL1 and elastin-related genes.
METHODS: Cultured human Tenon's capsule fibroblasts with high- and low-risk LOXL1 haplotypes were exposed to transforming growth factor (TGF)-β1, interleukin (IL)-6, homocysteine, oxidative stress, hypoxia, or ultraviolet (UV) radiation. Changes in the expression of LOXL1 and elastic constituents of PEX material and TGF-β1 were assessed by quantitative real-time PCR, Western blotting, immunohistochemistry, and electron microscopy.
RESULTS: Treatment of fibroblasts with TGF-β1, oxidative stress, UV light, and hypoxia induced a significant increase in expression levels of LOXL1 and elastic proteins, whereas the effect of IL-6 was limited to induction of elastic constituents. Immunohistochemistry and electron microscopy confirmed an upregulation of LOXL1 and elastic fiber proteins and their assembly into extracellular microfibrillar networks with focal aggregation of microfibrils into PEX-like fibrils on stimulation with TGF-β1 and oxidative stress. Basal and stimulated expression of LOXL1 mRNA and protein was slightly decreased in cells carrying the high-risk compared with the low-risk haplotype of LOXL1, but the differences between groups were statistically not significant.
CONCLUSIONS: The findings support the notion that both genetic and nongenetic fibrogenic factors, particularly TGF-β1 and oxidative stress, may cooperate in the stable accumulation of PEX aggregates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21948647     DOI: 10.1167/iovs.11-8361

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

1.  Nailfold capillary morphology in exfoliation syndrome.

Authors:  C C Cousins; J H Kang; C Bovee; J Wang; S H Greenstein; A Turalba; L Q Shen; S Brauner; T Boumenna; S Blum; H Levkovitch-Verbin; R Ritch; J L Wiggs; P A Knepper; L R Pasquale
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Relation between time spent outdoors and exfoliation glaucoma or exfoliation glaucoma suspect.

Authors:  Jae H Kang; Janey L Wiggs; Louis R Pasquale
Journal:  Am J Ophthalmol       Date:  2014-05-20       Impact factor: 5.258

Review 3.  Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.

Authors:  Teresa Borrás
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

Review 4.  Genetics of glaucoma.

Authors:  Janey L Wiggs; Louis R Pasquale
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

5.  Isoforms of TGF-β in the aqueous humor of patients with pseudoexfoliation syndrome and a possible association with the long-term stability of the capsular bag after cataract surgery.

Authors:  Justus G Garweg; Souska Zandi; Christin Gerhardt; Isabel B Pfister
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-28       Impact factor: 3.117

Review 6.  [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].

Authors:  U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

Review 7.  Is Autophagy Dysfunction a Key to Exfoliation Glaucoma?

Authors:  J Mario Wolosin; Robert Ritch; Audrey M Bernstein
Journal:  J Glaucoma       Date:  2018-03       Impact factor: 2.503

8.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

Review 9.  Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.

Authors:  Audrey M Bernstein; Robert Ritch; Jose M Wolosin
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

Review 10.  Exfoliation Syndrome and Solar Exposure: New Epidemiological Insights Into the Pathophysiology of the Disease.

Authors:  Aliya Z Jiwani; Louis R Pasquale
Journal:  Int Ophthalmol Clin       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.